Delcath to trial Hepzato drug device combo in colorectal cancer
Delcath System has received clearance from the US Food and Drug Administration (FDA) for an investigational new drug (IND) application …
Delcath System has received clearance from the US Food and Drug Administration (FDA) for an investigational new drug (IND) application …
Canadian life sciences company Medicus Pharma has partnered with Japanese healthcare consultancy Swanielle to expand its Phase II clinical trial …
US-based biopharmaceutical company Sudo Biosciences has initiated a Phase I trial of SUDO-550, a drug candidate designed to treat neuroinflammatory …
The popularity of GLP-1 receptor (GLP-1R) subcutaneous treatments for obesity has proved the demand for the drugs, but the lack …
Novocure is seeking regulatory approval in the US, EU, Japan and other key markets after the Phase III PANOVA-3 pancreatic …
The popularity of GLP-1 receptor (GLP-1R) subcutaneous treatments for obesity has proved the demand for the drugs, but the lack …
Novocure is seeking regulatory approval in the US, EU, Japan and other key markets after the Phase III PANOVA-3 pancreatic …
Qatar Foundation member Sidra Medicine has conducted the industry-sponsored ‘sunRIZE’ trial for paediatric congenital hyperinsulinism. The first pharmaceutical trial comes after …
Sweden-based Cantargia has commenced an expanded segment of the ongoing Phase I trial of its antibody, CAN10, with the first …
Minghui Pharmaceutical has reported positive topline outcomes from the randomised Phase III trial of its pan-Jak inhibitor, MH004 (tofacitinib etocomil) …
A pivotal investigator-led clinical trial for a new ‘pill-on-a-thread’ innovation for oesophageal cancer screening has welcomed its first patients, Cambridge …
Tryptamine Therapeutics (Tryp) has announced the completion of subject dosing in a Phase Ib clinical trial of its psilocin-based intravenous …
UK-based Albus Health (formerly BreathOx) has shared data revealing that its Albus Home AI-powered monitoring device can detect warning signs …
Takeda Canada has co-sponsored the Canadian Inflammatory Bowel Disease Research Consortium (CIRC) PIONEER Grant to boost clinical research efforts. The company …
A new combination therapy designed for some of the most aggressive forms of breast cancer has shown promising results in …